Purdue Pharma judge says Sacklers face ‘substantial risk’ of liability By Reuters

0 4
© Reuters. FILE PHOTO: Bottles of prescription painkiller OxyContin made by Purdue Pharma LP sit on a shelf at a local pharmacy in Provo, Utah, U.S. April 25, 2017. REUTERS/George Frey/File Photo By Maria Chutchian (Reuters) - The judge overseeing Purdue Pharma’s bankruptcy said on Monday that some members of the Sackler family who own the OxyContin maker face a “substantial risk” of liability and could be on the hook for "huge amounts of money" over claims the company fueled the opioid epidemic. U.S. Bankruptcy Judge Robert Drain in White Plains, New York, made the remark during closing arguments in a trial over Purdue’s proposed reorganization plan. Drain said he believes some Sacklers face liability, but that “the question is where you draw the line.” Under the deal, which Purdue says is worth more than $10 billion, the Sacklers would contribute approximately $4.5 billion and would receive legal protections against future opioid-related litigation. Drain d
Subscribe or log in to read the rest of this content.
Leave A Reply

Your email address will not be published.

At The Centre of Every Trade